A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment

Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment side effects. This case study reports a 49-year-old woman who presented to the severe asthma center with uncontrolled severe asthma des...

Descripción completa

Detalles Bibliográficos
Autores principales: Davison, John, Doe, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633044/
https://www.ncbi.nlm.nih.gov/pubmed/34877251
http://dx.doi.org/10.1016/j.rmcr.2021.101557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633044/
https://www.ncbi.nlm.nih.gov/pubmed/34877251
http://dx.doi.org/10.1016/j.rmcr.2021.101557

Ejemplares similares